Metabolism of 2-acetylaminofluorene. I. Metabolism in vitro, of 2-acetylaminofluorene and 2-acetylaminofluoren-9-one by hepatic enzymes

References

• Benkert K., Fries W., Kiese M., Lenk W. N-(9-hydroxy-9H-fluoren-2-yl)-acetamide and N-(9-oxo-9H-fluoren-2-yl)-acetamide: metabolites ofN-(9H-fluoren-2-yl)-acetamide. Biochemical Pharmacology 1975; 24: 1375–1380
   Web of Science ®Google Scholar
• Bielschowsky F. A metabolite of 2-acetylaminofluorene. Biochemical Journal 1945; 39: 287–289
   PubMedGoogle Scholar
• Björkhem I., Hamberg M. w-Oxidation of fatty acids. II. Enzymatic oxido-reduction of 17-hydroxy stearic acid. Journal of Biological Chemistry 1971; 246: 7417–7420
   PubMed Web of Science ®Google Scholar
• Booth J., Boyland F. The biochemistry of aromatic amines. 10. Enzymic N-hydroxylation of arylamines and conversion of arylhydroxylamines into o-aminophenols. Biochemical Journal 1964; 91: 362–369
   PubMed Web of Science ®Google Scholar
• Cramer J. W., Miller J. A., Miller E. C. N-Hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene. Journal of Biological Chemistry 1960; 235: 885–888
   PubMed Web of Science ®Google Scholar
• Dyer H. M. A comparison of the patterns of excretion and the carcinogenicity in the rat of 2-acetylaminofluorene and related compounds. Journal of the National Cancer Institute 1955; 16: 11–30
   PubMedGoogle Scholar
• Fries W., Kiese M., Lenk W. Oxidation of polycyclic N-arylacetamides to glycolamides and hydroxamic acids in rabbits. Xenobiotica 1973; 3: 525–540
   PubMed Web of Science ®Google Scholar
• Gerhardt O. Hydrozones and azines. I. Coloured ketazines. Monatshefte für Chemie 1920; 41: 199–214
   Google Scholar
• Grantham P. H. Separation of the urinary metabolites of N-2-fluorenylacetamide on columns of DEAE-cellulose anion exchange. Biochemical Pharmacology 1967; 16: 429–440
   PubMed Web of Science ®Google Scholar
• Gutmann H. R., Erickson R. R. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. Substrate specificity and mechanism of the reaction. Journal of Biological Chemistry 1972; 247: 660–666
   PubMed Web of Science ®Google Scholar
• Gutmann H. R., Peters J. H., Burtle J. G. The metabolism in vitro of fluorene derivatives by rat liver: hydroxylation and protein binding. Journal of Biological Chemistry 1956; 222: 373–386
   PubMedGoogle Scholar
• Irving C. C. N-Hydroxylation of the carcinogen 2-acetylaminofluorene by rabbit liver microsomes. Biochimica Biophysica Acta 1962; 65: 564–566
   PubMed Web of Science ®Google Scholar
• Lenk W., Rosenbauer-Thilmann R. Secondary oxygenation of the carcinogen 2-acetylaminofluorene (=2-AAF) in vitro and in vivo. Microsomes, Drug Oxidations, and Chemical Carcinogenesis, M. J. Coon, et al. Academic Press, New York 1980; Vol. 2: 1227–1230
   Google Scholar
• Lotlikar P. D., Enomoto M., Miller J. A., Miller E. C. Species variations in the N- and ring-hydroxylation of 2-acetylaminofluorene and effects of 3-methylcholanthrene pretreatment. Proceedings of the Society for Experimental Biology and Medicine 1967; 125: 341–346
   PubMed Web of Science ®Google Scholar
• Lotlikar P. D., Miller E. C., Miller J. A., Margreth A. The enzymatic reduction of the N-hydroxy derivatives of 2-acetylaminofluorene and related carcinogens by tissue preparations. Cancer Research 1965; 25: 1743–1752
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A., Enomoto M. The comparative carcinogenicities of 2-acetylaminofluorene and its N-hydroxy metabolite in mice, hamsters, and guinea pigs. Cancer Research 1964; 24: 2018–2026
   PubMed Web of Science ®Google Scholar
• Miller J. A., Sandin R. B., Miller E. C., Rusch H. P. The carcinogenicity of compounds related to 2-acetylaminofluorene. II. Variations in the bridges and the 2-substituent. Cancer Research 1955; 15: 188–199
   PubMed Web of Science ®Google Scholar
• Morris H. P., Velat C. A., Wagner B. P., Dahlgard M., Ray F. E. Studies of carcinogenicity in the rat of derivatives of aromatic amines related to N-2-fluorenylacetamide. Journal of the National Cancer Institute 1960; 2: 140–180
   Google Scholar
• Pan H. L., Fletcher T. L. Derivatives of fluorene. V. 9-Hydroxyfluorenes; reduction of fluorenones in the presence of aralkylideneamino groups. Journal of Organic Chemistry 1958; 23: 799–803
   Google Scholar
• Poirier L. A., Miller J. A., Miller J. A., Miller E. C. The N- and ringhydroxy-lation of 2-acetylaminofluorene and the failure to detect N-acetylation of 2-aminofluorene in the dog. Cancer Research 1963; 23: 790–800
   PubMed Web of Science ®Google Scholar
• Ray F. E., Wejebe O. O. Distribution of tritiated derivatives of fluorene in the rat. Journal of Pharmaceutical Sciences 1964; 53: 601–603
   PubMedGoogle Scholar
• Robinson H. W., Hogden C. G. The biuret reaction in the determination of serum proteins. II. Measurements made by a Dubosq colorimeter compared with values obtained by the Kjeldahl procedure. Journal of Biological Chemistry 1940; 135: 727–731
   Google Scholar
• Seal U. S., Gutmann H. R. The metabolism of the carcinogen N-(2-fluorenyl)acetamide by liver cell fractions. Journal of Biological Chemistry 1959; 234: 648–654
   PubMedGoogle Scholar
• Szarkowska L., Klingenberg M. On the role of ubiquinone in mitochondria. Spectro-photometric and chemical measurement of its redox reaction. Biochemische Zeitschrift 1963; 338: 674–697
   PubMedGoogle Scholar
• Thorgeirsson S. S., Jollow D. J., Sasame H. A., Green I., Mitchell J. R. The role of cytochrome P-450 in the N-hydroxylation of 2-acetylaminofluorene. Molecular Pharmacology 1973; 9: 398–404
   PubMed Web of Science ®Google Scholar
• Weisburger E. K., Weisburger J. H. Ortho-hydroxy derivatives of the carcinogen 2-acetylaminofluorene. Journal of Organic Chemistry 1954; 19: 964–972
   Google Scholar
• Weisburger E. K., Weisburger J. H. 2-Acetylamino-5-hydroxyfluorene, a metabolite of the carcinogen 2-acetylaminofluorene. Journal of Organic Chemistry 1955; 20: 1396–1401
   Google Scholar